767 related articles for article (PubMed ID: 16211302)
21. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
22. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC.
Pan Q; Liu B; Liu J; Cai R; Liu X; Qian C
Acta Oncol; 2008; 47(1):135-44. PubMed ID: 17934893
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L
J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017
[TBL] [Abstract][Full Text] [Related]
24. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
Wang Z; Sampath J; Fukuda S; Pelus LM
Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298
[TBL] [Abstract][Full Text] [Related]
25. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
Braeuer SJ; Büneker C; Mohr A; Zwacka RM
Mol Cancer Res; 2006 Oct; 4(10):715-28. PubMed ID: 17050666
[TBL] [Abstract][Full Text] [Related]
26. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
[TBL] [Abstract][Full Text] [Related]
28. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
29. Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL.
Ganten TM; Koschny R; Haas TL; Sykora J; Li-Weber M; Herzer K; Walczak H
Hepatology; 2005 Sep; 42(3):588-97. PubMed ID: 16037944
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA
Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911
[TBL] [Abstract][Full Text] [Related]
31. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
[TBL] [Abstract][Full Text] [Related]
32. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells.
Chen W; Wang X; Zhuang J; Zhang L; Lin Y
Carcinogenesis; 2007 Oct; 28(10):2114-21. PubMed ID: 17548900
[TBL] [Abstract][Full Text] [Related]
33. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
34. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J
Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022
[TBL] [Abstract][Full Text] [Related]
35. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
36. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.
Roth W; Wagenknecht B; Klumpp A; Naumann U; Hahne M; Tschopp J; Weller M
Cell Death Differ; 2001 Apr; 8(4):403-10. PubMed ID: 11550092
[TBL] [Abstract][Full Text] [Related]
37. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.
Lima RT; Martins LM; Guimarães JE; Sambade C; Vasconcelos MH
Cancer Gene Ther; 2004 May; 11(5):309-16. PubMed ID: 15031723
[TBL] [Abstract][Full Text] [Related]
38. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
[TBL] [Abstract][Full Text] [Related]
39. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis.
Ou D; Wang X; Metzger DL; James RF; Pozzilli P; Plesner A; Korneluk RG; Verchere CB; Tingle AJ
Hum Immunol; 2005 Mar; 66(3):274-84. PubMed ID: 15784465
[TBL] [Abstract][Full Text] [Related]
40. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
Yang W; Sun T; Cao J; Liu F
Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
